A new PCR test measures cellular immunity conferred by vaccines and by SARS-CoV2 infection

Jordi Cano, researcher at the National Center for Biotechnology (CNB) of the Carlos III Institute of Health (ISCIII). Carlos III Health Institute (ISCIII) A rapid test detects people who need a booster vaccine against Covid Researchers from the National Microbiology Center of the Carlos III Health Institute (ISCIII) have co-led an international investigation published in … Read more

Babies exposed to SARS-CoV-2 before birth may have neurodevelopmental deficiencies

Babies exposed to SARS-CoV-2 virus during pregnancy could be affected by neuronal development, warns a preliminary analysis by the European Psychiatric Association, presented at the 30th European Congress of Psychiatry (EPA, June 4-7, 2022). Not all babies born to mothers infected with coronavirus have differences in neurodevelopment. But our data show that their risk is … Read more

Covid, the most contagious BA.5 sub-variant of the other Omicron – Biotech

The BA.5 subvariant is more transmissible than the other Omicron subvariants due to at least two mutations which allow it to bind to human cells more effectively. The data are online on the BiorXiv platform, which hosts studies not yet reviewed by the scientific community, and are the result of research conducted in Japan and … Read more

COVID-19: More than 56 million 897 thousand doses of the SARS-CoV-2 vaccine have been administered – Ministry of Health

The Ministry of Health reports that with a cut-off date of Wednesday, June 1, according to data from the Department of Statistics and Health Information, 56,897,029 doses of the vaccine against COVID-19 have been administered in the country. Regarding the target population of 15,200,840 people, which considers people aged 18 and over, 13,908,234 first doses, … Read more

Inverse relationship identified between SARS-CoV-2 and influenza infections

The coronavirus (COVID-19) pandemic has placed operational burdens on infectious disease epidemiology, preventing their routine surveillance. Despite these challenges, continued influenza virus surveillance is necessary for the production of new vaccines each year. Symptoms of COVID-19 and influenza are quite similar, as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus both target the … Read more

Preclinical study shows that ISR-052 provides long term protection against SARS-CoV-2

ISR has conducted an animal study that shows that immunological memory remains 6 months after two doses of the company’s nasal vaccine candidate, ISR-52, were given against SARS-CoV-2. ”The study shows that vaccination with application in the upper respiratory tract gives rise to long-term immunological memory, which in turn indicates long-term protection against SARS-CoV-2. Six … Read more

COVID-19: More than 56 million 416 thousand doses of the SARS-CoV-2 vaccine have been administered – Ministry of Health

The Ministry of Health reports that, with a cut-off date of Monday, May 30, according to data from the Department of Statistics and Health Information, 56,416,908 doses of the COVID-19 vaccine have been administered in the country. Regarding the target population of 15,200,840 people, which considers people aged 18 and over, 13,906,271 first doses, 13,689,137 … Read more

Researchers identify human monoclonal antibody capable of broadly neutralizing multiple variants of SARS-CoV-2, SARS-CoV and other coronaviruses.

In a recent study published in Science Translational Medicineresearchers identified 10-40, a human monoclonal antibody (mAb) with potent neutralizing activity against severe acute respiratory syndrome coronavirus (SARS-CoV), SARS-CoV-2, and related sarbecoviruses. Study: A class of antibodies with a common CDRH3 motif largely neutralizes sarbecoviruses. Image Credit: ustas7777777/Shutterstock The emergence of multiple variants of SARS-CoV-2 with … Read more

SARS-CoV-2 infection in companion animals – News, CHUVAC, Clinics, IHAP, Research

SARS-CoV-2 infection in companion animals: prospective serological survey and analysis of risk factors in France. Thanks to the collaboration of practicing veterinarians distributed throughout the territory and the collaboration between theUMR IHAP and the CHUVACthe sera of 165 dogs and 143 cats were analyzed for antibodies against SARS-CoV-2 (the virus responsible for COVID-19). Approximately 5% … Read more

The study aims to determine whether people who have contracted a primary infection with SARS-CoV-2 have post-acute sequelae.

In a recent study published in Nature Medicineresearchers characterized the long-lasting coronavirus 2019 (COVID-19) after a breakthrough infection of COVID-19. Study: Long COVID after SARS-CoV-2 breakthrough infection. Image credit: creativeneko/Shutterstock Long COVID is the manifestation of acute sequelae after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Further research is needed to understand the … Read more